Antiphospholipid Antibody Syndrome, Myasthenia Gravis, and Diabetes Mellitus: A Mosaic of Autoimmune Entities in A Pregnant Patient (Record no. 7952)

MARC details
000 -LEADER
fixed length control field 01676nam a22002417a 4500
001 - CONTROL NUMBER
control field 5005
003 - CONTROL NUMBER IDENTIFIER
control field PILC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240720152606.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160505b2012 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Transcribing agency FEU-NRMF MEDICAL LIBRARY
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number RES OB-GYNE 2012 0001
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Acada, Hanna N., M.D.
245 ## - TITLE STATEMENT
Title Antiphospholipid Antibody Syndrome, Myasthenia Gravis, and Diabetes Mellitus: A Mosaic of Autoimmune Entities in A Pregnant Patient
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 2012
336 ## - CONTENT TYPE
Content type term Text
337 ## - MEDIA TYPE
Media type term Unmediated
338 ## - CARRIER TYPE
Carrier type term Volume
502 ## - DISSERTATION NOTE
Degree type MEDICINE
Miscellaneous information Research project
520 ## - SUMMARY, ETC.
Summary, etc. This is a case of a 34-year old, Gravida 5 Para 0 (0040), Pregnancy Uterine 36 weeks, in breech presentation, who presented with poor obstetrical history, she was diagnosed with Antiphospholipid antibody Syndrome. Myasthenia Gravis, and Gestational Diabetes Mellitus-Insulin requiring, and was admitted due to preterm labor. The patient was given the standard management for these clinical entities. For APAS low molecular weight and low dose aspirin, for myasthenia Gravis Pyridostigmine, and for Gestational Diabetes Mellitus, fetal suerveillance via weekly BPS and NST, CBG monitoring, and insulin. The patient was tocolysed with calcium channel blocker (Nifedine) until she reach 38 weeks wherein she then underwent low segment cesarean section which resulted to ag ood baby outcome. APAS and Myasthenia Gravis, the two being autoimmune in origin, are due to the presence of autoantiboides. Therefore the possibilility that her Gestational Diabetes Mellitus could also be of autoimmune origin was considered.
887 ## - NON-MARC INFORMATION FIELD
Content of non-MARC field RES RC00370
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Research
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     Far Eastern University - Nicanor Reyes Medical Foundation Far Eastern University - Nicanor Reyes Medical Foundation Research 02/11/2015   OB20120001 R000370 03/03/2016 07/22/2016 Research